Merck & Co (NYSE:MRK) reported quarterly earnings of $1.87 per share which beat the analyst consensus estimate of $1.69 by 10.65 percent. This is a 42.75 percent increase over earnings of $1.31 per share from the same period last year. The company reported quarterly sales of $14.59 billion which beat the analyst consensus estimate of $13.87 billion by 5.21 percent. This is a 27.99 percent increase over sales of $11.40 billion the same period last year.
USA Continuing Claims for Jun 25 3.339M vs 3.335M Est; Prior 3.469M
USA Continuing Claims for Jun 25 3.339 million vs 3.335 million consensus estimate. The prior reading was 3.469 million.
